129773928521093750_134Hexun homepage established mobile phone version of the stock/fund market for micro-blogging news blog live small company stocks the major new share placements by gem new third sector brokers New York themesBulletin deal prompted the financial calendar of earnings release memo block trade in thousands of shares of financial market Center collection of funds flowing to new share purchase financing Twitter pioneer financial management training in the daily limit of the unit gather Forum hexun.com stock > body font size print RSSMarch 27, 2012 from: jianghai hexun stock shares quotations zheshang securities: jianghai shares (002484 shares) (002484) strong earnings growth to determine investment: characteristics of industrial electronics with cycle after, although 2012 quarterly company boom waveDynamic, performance or hard to surprise
tera gold, but we expect that the company will be clearly felt in the 2 quarter industry boom up when company product order will be steadily enhanced, capacity utilization will gradually recover from current average 80% above 90%. Investment rating: we believe that reasonable valuations of companies in 2012 in 22-26 PE, maintaining a "buy"Ratings. Tuguang Huadong medicines market securities: Huadong medicine (000963
tera power leveling, unit) (000963), in line with expected growth in net profit investments: with the new specifications share increase, antineoplastic, diabetes new areas such as promotion, expected this year is expected to grow 40%. Endocrine line revenue of $ 440 million last year, an increase of 26%. FreeDisease inhibitor income of 450 million Yuan last year, an increase of 11%. Investment rating: corbrin capsule is expected to develop into 1 billion level. We are optimistic about the company's prescription drug team
tera gold, 2012 PE, target price $ 33, maintaining a "buy" rating.
Others:
No comments:
Post a Comment